FitKids360: Design, Conduct, and Outcomes of a Stage 2 Pediatric Obesity Program by Saturley, Heather, Peterson, Tom, Murphy, Megan, Graybill, Jill, DeLaFuente, Kimberly, Yee, Kimbo E., Guseman, Emily H., Howard, Kathleen, Eisenmann, Joey C., Tucker, Jared M., Roberts, Meggie

Get full text

Improvements in Family Nutrition and Physical Activity during FitKids360: Associations with Adiposity Changes 3107 Board #12 June 2 3 30 PM - 5 00 PM by Delafuente, Kim, Tucker, Jared, Howard, Kathy, Graybill, Jill, Welk, Gregory

Get full text

Aspartyl alpha-((diphenylphosphinyl)oxy)methyl ketones as novel inhibitors of interleukin-1 beta converting enzyme. Utility of the diphenylphosphinic acid leaving group for the inh... by Dolle, R E, Singh, J, Whipple, D, Osifo, I K, Speier, G, Graybill, T L, Gregory, J S, Harris, A L, Helaszek, C T, Miller, R E

Get full text

Characterization of a continuous fluorogenic assay for calpain I. Kinetic evaluation of peptide aldehydes, halomethyl ketones and (acyloxy)methyl ketones as inhibitors of the enzym... by Harris, Alex L., Gregory, Jill S., Maycock, Alan L., Graybill, Todd L., Osifo, I.Kelly, Schmidt, Stanley J., Dolle, Roland E.

Get full text

Synthesis and evaluation of azapeptide-derived inhibitors of serine and cysteine proteases by Graybill, Todd L., Ross, Mitchell J., Gauvin, Bruce R., Gregory, Jill S., Harris, Alex L., Ator, Mark A., Rinker, James M., Dolle, Roland E.

Get full text

Aspartyl .alpha.-((Diphenylphosphinyl)oxy)methyl Ketones as Novel Inhibitors of Interleukin-1.beta. Converting Enzyme. Utility of the Diphenylphosphinic Acid Leaving Group for the... by Dolle, Roland E, Singh, Jasbir, Whipple, David, Osifo, I. Kelly, Speier, Gary, Graybill, Todd L, Gregory, Jill S, Harris, Alex L, Helaszek, Carla T

Get full text

Inhibition of human erythrocyte calpain I by novel quinolinecarboxamides by Graybill, Todd L., Dolle, Roland E., Osifo, Irennegbe K., Schmidt, Stanley J., Gregory, Jill S., Harris, Alex L., Miller, Matthew S.

Get full text